Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?
After a tough 2013 for Abbott Laboratories (NYSE: ABT), can it beat sector peers Baxter International and Edwards Lifesciences in 2014?
Multiple Setbacks May Spell Opportunity at Medtronic, Inc.
Clinical disappoints and more aggressive rivals have pushed this large med-tech into value territory.
Edwards Lifesciences Corp. Still Trying To Regain Footing
Edwards Lifesciences has struggled to meet growth expectations and Medtronic is breathing down its neck.